Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23241,79,0.66 [0.32-1.34],0.2489987367147439
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23728,126,0.90 [0.54-1.48],0.6673067649330376
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23519,867,1.01 [0.84-1.20],0.941843016250287
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23745,261,1.10 [0.81-1.51],0.5311359375183833
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23070,2337,0.92 [0.82-1.03],0.1534524381315837
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23292,1765,1.05 [0.93-1.19],0.4577828145769154
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23574,844,0.91 [0.75-1.10],0.336070610235421
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23682,37,0.56 [0.19-1.66],0.2951506549609926
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22662,538,0.82 [0.64-1.06],0.1366164242543235
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21906,516,1.05 [0.84-1.32],0.6497622030282373
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22122,148,1.03 [0.66-1.59],0.9081283506452198
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17617,1023,1.04 [0.88-1.22],0.6620293105282247
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21925,249,1.11 [0.80-1.53],0.5313912507287384
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23718,988,0.95 [0.80-1.13],0.5903640749437885
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23801,317,1.21 [0.93-1.58],0.1566849097058216
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23180,528,0.99 [0.79-1.25],0.9377983617263098
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23751,589,0.83 [0.66-1.06],0.1381607517789193
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22858,128,0.87 [0.53-1.45],0.598519851277773
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23842,28,0.74 [0.23-2.34],0.6052594350500913
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23681,519,0.84 [0.66-1.09],0.19342138861553
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23709,64,1.06 [0.56-2.01],0.8586602552317685
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23752,152,1.14 [0.76-1.69],0.5267041014418745
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23738,138,1.03 [0.67-1.61],0.8790231249082064
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22946,294,0.99 [0.72-1.35],0.9490124590967752
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22858,206,1.06 [0.74-1.52],0.7351576823204604
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22797,67,1.52 [0.97-2.41],0.0703456451978878
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23816,43,1.14 [0.53-2.44],0.7395689341534155
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23787,112,1.02 [0.62-1.66],0.9455702834640192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23712,37,1.21 [0.57-2.58],0.6209756490553442
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23718,43,0.90 [0.39-2.08],0.8034986810636544
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23585,271,1.30 [0.99-1.70],0.0572330720383045
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23765,62,1.10 [0.59-2.06],0.7544962643378598
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23740,66,0.65 [0.30-1.41],0.2712941771047857
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10630,36,2.12 [1.30-3.45],0.0026435362286547
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23663,997,1.12 [0.96-1.31],0.1488801220190635
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of meninges,23831,44,1.22 [0.61-2.44],0.5666485015229992
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23811,46,0.91 [0.40-2.09],0.8277021071322833
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23822,79,1.07 [0.61-1.89],0.8149800959584628
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of ovary,13155,83,1.46 [0.97-2.20],0.0703021373850069
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23834,234,1.14 [0.83-1.58],0.4084448283861143
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23830,181,1.13 [0.79-1.62],0.5006994746103821
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23775,45,0.77 [0.32-1.90],0.5751678671649161
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23838,154,1.17 [0.79-1.73],0.4330534123828817
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23804,242,0.95 [0.67-1.35],0.7851893946678588
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23772,465,1.16 [0.92-1.45],0.2081117608602781
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23834,259,1.33 [1.01-1.75],0.041370292363514
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Carcinoma in situ of breast,11293,74,0.52 [0.25-1.12],0.0962088880105251
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11332,84,0.64 [0.32-1.25],0.1897413856554533
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20582,31,0.80 [0.50-1.27],0.3445729745690902
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20584,33,0.89 [0.34-2.33],0.8061785825669704
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23803,93,1.10 [0.66-1.84],0.7083456709408931
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma, any site",23803,91,1.13 [0.68-1.88],0.6263739508939246
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Leiomyoma of uterus,12603,340,1.20 [0.94-1.54],0.1503132632265157
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lung cancer and mesothelioma,17659,147,0.81 [0.50-1.33],0.4111833715023817
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lymphoid leukaemia,20577,26,0.56 [0.15-2.02],0.3747914447750137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20678,127,0.84 [0.51-1.38],0.4873833805857521
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20626,75,1.26 [0.75-2.11],0.3779535020005636
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11378,66,0.71 [0.34-1.48],0.3590359745561104
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20596,45,1.32 [0.69-2.52],0.4048865902436511
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20601,50,1.37 [0.77-2.46],0.2847863786546333
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20614,63,1.12 [0.60-2.08],0.7309423892965156
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11359,47,1.65 [1.01-2.68],0.0436221701837164
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20600,49,0.94 [0.43-2.07],0.8835011412045148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9580,341,1.00 [0.75-1.33],0.9946826770758386
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20635,84,1.18 [0.70-1.98],0.5387247561796213
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20597,46,1.62 [0.94-2.80],0.079865924440355
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20607,56,0.89 [0.43-1.87],0.7625159258161512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi,23642,190,1.18 [0.84-1.66],0.3273084704061481
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23803,87,1.11 [0.66-1.86],0.7048812386118026
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanoma in situ,20559,37,1.30 [0.66-2.58],0.4449941361457908
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20604,53,0.69 [0.29-1.61],0.3852771393178207
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20651,100,0.82 [0.46-1.47],0.5074319186403776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20649,98,0.88 [0.49-1.60],0.6849547741734087
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20607,56,0.79 [0.36-1.73],0.5639378461472666
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,23685,128,1.06 [0.68-1.66],0.7870298276963767
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21101,550,0.95 [0.76-1.19],0.6787813344756672
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21131,580,0.97 [0.78-1.20],0.768375654252126
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23596,255,0.96 [0.69-1.35],0.8259890405519259
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22623,39,1.66 [0.95-2.90],0.0769852408218496
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23407,66,0.89 [0.45-1.79],0.7491998812373817
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23145,1905,1.04 [0.92-1.17],0.5473717682795518
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22853,19,1.26 [0.44-3.57],0.6659444868277578
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23540,28,0.31 [0.08-1.21],0.0911319429179142
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23458,874,1.13 [0.96-1.34],0.1325776462014927
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23458,874,1.13 [0.96-1.34],0.1325776462014927
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22632,48,1.25 [0.64-2.45],0.506881859922956
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23604,770,0.99 [0.82-1.20],0.9060438196235404
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23600,88,1.28 [0.80-2.04],0.3069544941593332
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23388,47,1.65 [0.97-2.82],0.0638228165757374
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23379,38,1.20 [0.56-2.60],0.6358056049343201
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23677,165,0.86 [0.55-1.34],0.5080090549479629
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23772,60,1.26 [0.71-2.26],0.4267821864816095
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23654,142,0.95 [0.60-1.50],0.8333932166248925
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22892,58,0.51 [0.21-1.22],0.1311033019744083
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20448,176,1.27 [0.90-1.81],0.1783721483643165
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22166,104,1.15 [0.71-1.87],0.5756532937654981
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22184,122,1.07 [0.66-1.74],0.7797045208443875
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20303,31,1.27 [0.54-2.95],0.5840813027060803
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22126,64,0.40 [0.16-0.96],0.0405109115499611
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21820,126,0.77 [0.45-1.31],0.3329688903804269
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23714,139,0.78 [0.47-1.30],0.3456653453975721
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23620,45,0.96 [0.43-2.13],0.9213244517186622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23607,32,1.17 [0.51-2.68],0.7124381546757779
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23488,1426,0.96 [0.83-1.11],0.5769841680324578
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21349,1386,0.98 [0.85-1.13],0.7674209408231958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20311,39,0.82 [0.32-2.08],0.6696964792633737
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22422,50,1.22 [0.64-2.35],0.5416488198848425
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20432,160,1.19 [0.81-1.74],0.3798242744642429
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20325,53,0.83 [0.38-1.82],0.6405330106130764
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22349,2077,0.96 [0.85-1.08],0.5167392197455589
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20378,106,1.42 [0.94-2.13],0.0920827379708105
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20609,337,1.22 [0.95-1.58],0.1236999104387795
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23760,226,1.06 [0.75-1.49],0.7492497210585668
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23626,92,1.40 [0.91-2.14],0.1217905342730878
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20362,90,1.25 [0.76-2.05],0.38143733181906
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20306,34,1.73 [0.97-3.10],0.0648097371226579
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23472,1100,0.92 [0.78-1.08],0.3182713218694863
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20381,109,1.25 [0.79-1.97],0.3391629604507613
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20400,128,1.09 [0.69-1.71],0.7243385613790458
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20614,342,1.03 [0.77-1.36],0.8518697207500716
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20328,56,1.08 [0.54-2.16],0.81933640482749
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23620,86,1.21 [0.74-2.00],0.4459755208712096
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20532,260,1.07 [0.78-1.48],0.6621410280985831
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20540,268,0.93 [0.66-1.30],0.6565109982445578
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21742,48,0.72 [0.30-1.75],0.4680423329865129
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23238,2966,0.98 [0.89-1.08],0.7042093695306952
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22395,23,0.81 [0.24-2.69],0.7268549985113926
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22424,52,0.74 [0.32-1.70],0.4814635552465584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23686,1674,0.98 [0.86-1.12],0.789439985688356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23688,1670,0.98 [0.86-1.13],0.8187657494556189
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22403,31,0.81 [0.29-2.29],0.6965084878549206
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23562,1068,0.95 [0.80-1.12],0.5340740874085073
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21046,774,1.05 [0.87-1.27],0.5979693853385097
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23836,105,0.89 [0.51-1.55],0.6850827875058141
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23606,31,0.53 [0.16-1.77],0.3004436736732727
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22571,77,1.17 [0.68-2.03],0.5664540280973355
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22593,99,1.24 [0.78-1.96],0.3687830425476571
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20381,109,1.04 [0.63-1.70],0.8864371618466123
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22283,105,1.06 [0.63-1.77],0.8267542111107966
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1485,57,1.63 [1.04-2.56],0.0338127215334804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1581,166,1.56 [1.11-2.19],0.0099758805618862
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22213,35,0.40 [0.12-1.31],0.1297000578725118
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1457,29,0.83 [0.25-2.77],0.7604617451943317
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23488,1310,0.94 [0.81-1.10],0.4535926994413974
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23634,59,0.58 [0.25-1.36],0.21185344628182
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21939,245,1.04 [0.75-1.44],0.8246616655522705
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20618,346,1.18 [0.91-1.52],0.2193052454104391
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23760,147,1.13 [0.75-1.70],0.5547953031698761
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23191,49,1.42 [0.79-2.58],0.2444555734058942
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22748,691,1.06 [0.87-1.29],0.5512758804176552
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23235,93,1.17 [0.71-1.93],0.5314478195553175
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23169,27,1.47 [0.74-2.95],0.2738619815850049
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23236,94,1.19 [0.72-1.96],0.490578619625524
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16926,787,0.98 [0.81-1.18],0.7936112691418089
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,AV-block,21700,158,0.84 [0.53-1.33],0.4553423208543584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23812,225,1.00 [0.71-1.43],0.9825340267686856
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16231,92,1.05 [0.60-1.81],0.8722161101222013
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21656,114,1.02 [0.62-1.69],0.929753732530699
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21614,72,1.04 [0.56-1.93],0.9075440686943868
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23844,15,1.58 [0.59-4.23],0.3593539759792361
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,22006,464,1.05 [0.82-1.34],0.7021350736898475
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23215,1166,1.01 [0.87-1.18],0.8883349896907541
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22143,5225,0.99 [0.92-1.06],0.6956790170028876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22836,154,1.12 [0.75-1.69],0.5724463016098102
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Endocarditis,21582,40,0.87 [0.35-2.16],0.7720651634302466
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23735,442,1.23 [0.98-1.55],0.0677600011589302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,22635,4257,0.98 [0.90-1.07],0.6600107789670838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22643,4265,0.99 [0.91-1.07],0.7196988089244561
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23692,48,1.09 [0.52-2.25],0.8257727768096338
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18457,79,1.09 [0.61-1.94],0.7641413892939849
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18417,39,0.64 [0.23-1.77],0.3884850924376296
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,23757,591,1.14 [0.93-1.40],0.1929504227629416
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23384,57,1.43 [0.81-2.52],0.2203769455464106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23352,1295,1.00 [0.86-1.16],0.9561349501614812
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23649,270,1.01 [0.73-1.40],0.9497639751219178
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21724,182,1.18 [0.82-1.69],0.3784330474809679
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23623,523,0.96 [0.76-1.22],0.7515775355019909
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22482,425,0.92 [0.70-1.21],0.5569564932444393
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23793,105,0.92 [0.53-1.60],0.7742569343927234
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23829,182,0.87 [0.57-1.34],0.5352921320370192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22713,31,0.89 [0.32-2.47],0.8168847025075182
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other aneurysm,23181,39,0.73 [0.27-1.94],0.5252436781858825
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21764,222,1.17 [0.85-1.63],0.3379587866847832
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23201,59,1.41 [0.86-2.33],0.1778357253297055
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23270,128,1.21 [0.79-1.84],0.3789160866020953
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21653,111,1.28 [0.82-1.99],0.2824926449612312
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22743,61,1.42 [0.83-2.43],0.1999514344708084
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22727,45,0.72 [0.29-1.81],0.4894648233309031
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23162,34,1.32 [0.64-2.73],0.4525454177122711
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22760,78,1.74 [1.16-2.60],0.0072884363445873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22054,512,1.05 [0.83-1.32],0.6968528998077157
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23206,40,0.37 [0.12-1.14],0.0835238360244586
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23444,302,1.10 [0.82-1.47],0.5185294831163063
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23454,137,0.77 [0.46-1.28],0.3106696566003953
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23333,205,1.20 [0.86-1.68],0.2742927092967887
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16345,206,1.30 [0.96-1.77],0.092637175431413
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23302,181,0.81 [0.52-1.26],0.356021515556857
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22897,215,1.19 [0.85-1.65],0.3069701096113524
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23603,286,0.98 [0.72-1.35],0.9094723266923904
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23806,282,1.33 [1.03-1.72],0.0306435587961244
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21687,145,1.17 [0.78-1.75],0.4611140956353161
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23451,134,0.82 [0.49-1.37],0.4492977160800503
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23225,97,1.01 [0.59-1.73],0.9828851395607898
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23643,316,1.07 [0.80-1.43],0.6450127690948806
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23621,348,1.01 [0.76-1.35],0.9284529838280222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23365,50,0.96 [0.44-2.11],0.9240380741362568
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23190,49,1.33 [0.72-2.46],0.3643118130460513
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23494,115,1.02 [0.63-1.66],0.9320562105649588
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23257,157,1.07 [0.71-1.61],0.7472777943332265
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,22951,269,0.99 [0.72-1.37],0.9671217563043072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23152,45,1.43 [0.77-2.66],0.2524818375508291
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23686,449,1.07 [0.84-1.36],0.589774543929026
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23700,319,1.08 [0.81-1.44],0.5969823452849834
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21232,1225,0.98 [0.84-1.14],0.7990625513253825
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,23183,3176,0.98 [0.89-1.08],0.7068920610620675
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23646,371,1.09 [0.84-1.42],0.522746924369872
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21464,1457,0.94 [0.81-1.09],0.4088281614655275
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20084,77,1.17 [0.69-2.00],0.56103589690854
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,23363,1328,1.06 [0.91-1.23],0.4719030329392478
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21528,1521,1.04 [0.90-1.19],0.6170739610017395
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Vascular dementia,23745,17,0.81 [0.20-3.35],0.7707361480456454
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23843,63,0.84 [0.41-1.72],0.6335095826543314
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Bell's palsy,22397,68,1.53 [0.96-2.44],0.0753158585860072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22748,419,1.17 [0.93-1.48],0.1765283649559784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23529,178,0.96 [0.64-1.44],0.8421592857728436
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23768,187,0.89 [0.59-1.34],0.5707205301120325
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23714,22,1.05 [0.36-3.08],0.9307946447127518
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23833,49,0.96 [0.45-2.08],0.9209973963809932
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23403,52,1.79 [1.15-2.79],0.0102828911224824
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Epilepsy,22493,222,0.96 [0.67-1.38],0.8213483419748736
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23418,1147,1.06 [0.91-1.23],0.4425879043204129
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23816,167,0.95 [0.62-1.44],0.8025721995976564
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23398,1424,1.10 [0.96-1.25],0.1583110076015927
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23518,44,1.22 [0.59-2.52],0.5828049092852088
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,23717,136,0.90 [0.55-1.46],0.6598639894623437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23395,44,1.63 [0.95-2.78],0.0758839940688736
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23822,59,0.91 [0.44-1.89],0.8066360001748321
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22393,64,1.53 [0.95-2.46],0.0780093116680158
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22399,70,0.91 [0.46-1.78],0.7762024048940841
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Memory loss,23713,65,1.23 [0.69-2.19],0.4891766800865137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Migraine,22632,361,1.06 [0.82-1.38],0.655066023677801
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23767,327,0.98 [0.73-1.32],0.9093449487389744
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Motor neuron disease,17327,91,0.89 [0.49-1.61],0.7042228494831233
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23658,130,1.01 [0.64-1.60],0.9725795001684446
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23314,985,1.11 [0.95-1.30],0.1954191725901411
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,22578,2631,1.03 [0.93-1.14],0.5255281753922499
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23757,65,1.00 [0.51-1.93],0.9915671203165132
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22664,335,0.93 [0.69-1.26],0.6464152725140474
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23784,203,1.19 [0.85-1.67],0.3173690588862957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19877,276,0.95 [0.68-1.31],0.7394622519314216
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23403,52,0.78 [0.34-1.76],0.5450851995544792
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23453,102,1.14 [0.70-1.85],0.605357629068056
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23720,71,0.44 [0.19-1.00],0.0495297100615267
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22415,86,1.37 [0.87-2.17],0.1774249610364434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22327,56,1.35 [0.76-2.39],0.3082182082763752
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23736,385,1.12 [0.87-1.44],0.3841900493180962
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22774,503,1.07 [0.85-1.35],0.5506151340671217
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23830,75,1.40 [0.87-2.26],0.1608084561411066
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23406,55,1.02 [0.51-2.03],0.959096351196847
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23842,33,0.47 [0.14-1.53],0.2084073814505274
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23635,442,1.20 [0.96-1.52],0.1137829023346337
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23613,32,0.60 [0.19-1.88],0.3799532658845493
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23828,115,0.84 [0.49-1.43],0.5156806878427742
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22356,27,1.28 [0.53-3.09],0.5870744094268712
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23843,64,0.85 [0.42-1.72],0.6498012432572338
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23733,16,0.85 [0.20-3.56],0.8204333285937571
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23418,34,0.50 [0.16-1.58],0.2344216412286816
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23528,185,1.42 [1.05-1.91],0.0222816489966629
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23772,168,1.14 [0.77-1.68],0.5226639531833048
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23189,33,1.46 [0.73-2.89],0.2809704333416798
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23222,66,1.18 [0.66-2.12],0.5744406096051483
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23760,29,0.39 [0.10-1.43],0.1533247184693817
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23677,58,0.46 [0.19-1.12],0.0879182023044685
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1460,32,0.93 [0.31-2.76],0.8965661637118711
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1725,68,1.67 [1.08-2.60],0.0212432813872103
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23459,75,1.19 [0.70-2.05],0.5172515368466835
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23738,540,1.14 [0.93-1.41],0.2050923629865579
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23570,414,1.07 [0.83-1.36],0.6085497524876393
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23276,120,0.90 [0.55-1.48],0.6762865617777591
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23762,419,1.11 [0.87-1.41],0.3879438138387975
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23835,50,0.76 [0.33-1.77],0.5261454502422274
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23696,353,1.17 [0.91-1.51],0.215721400980274
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23807,188,0.97 [0.66-1.43],0.8634110117296006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23789,116,1.10 [0.70-1.74],0.6703141478334238
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23171,15,0.75 [0.16-3.50],0.7158134082970602
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23182,26,0.61 [0.17-2.14],0.4363290136151243
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23186,30,0.64 [0.21-2.02],0.4506060818768823
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23803,331,1.19 [0.92-1.54],0.1834040975739359
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23552,80,1.03 [0.58-1.83],0.9149389589010782
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23364,21,1.30 [0.53-3.22],0.5697654437745325
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23679,60,1.28 [0.73-2.25],0.3917807520216726
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23749,130,0.86 [0.52-1.41],0.5392076410688464
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23489,146,0.85 [0.53-1.37],0.5093330362772206
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23739,66,1.02 [0.54-1.91],0.9509737452783016
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23687,215,1.18 [0.85-1.63],0.3266000549285493
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23482,98,1.16 [0.72-1.89],0.5419571983681407
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23224,926,0.98 [0.83-1.17],0.8568481029957273
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23727,108,0.75 [0.42-1.33],0.3222561117827037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23821,97,0.90 [0.51-1.58],0.7024459020241951
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23384,228,1.01 [0.72-1.43],0.9473228366296385
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23655,36,0.96 [0.39-2.36],0.933682068124198
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23819,34,1.06 [0.45-2.52],0.888899667550862
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23192,36,0.62 [0.22-1.78],0.373925298388045
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23256,100,0.87 [0.49-1.52],0.6225558029082523
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23255,57,0.97 [0.48-1.98],0.9380409733968188
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23391,48,0.82 [0.36-1.88],0.64529664475495
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23241,43,0.88 [0.38-2.06],0.7722504097397013
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23518,46,1.29 [0.67-2.47],0.4478042961681805
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23553,81,1.19 [0.70-2.03],0.5184631038985512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23231,75,0.61 [0.29-1.29],0.195782723148467
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23302,104,0.83 [0.47-1.45],0.5145665695421404
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23227,29,0.95 [0.34-2.66],0.9276691660117824
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23018,720,1.09 [0.91-1.31],0.3399580475253492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23200,44,0.45 [0.16-1.25],0.127838229012906
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23652,268,0.89 [0.63-1.25],0.4979735593310579
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23415,31,0.60 [0.19-1.94],0.3968537178796477
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23494,110,0.84 [0.49-1.46],0.538992156068302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23667,58,0.69 [0.31-1.55],0.3711826103682317
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23803,78,0.99 [0.54-1.82],0.9789009849500134
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23734,122,0.54 [0.30-0.99],0.0464736366151462
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23658,49,1.03 [0.49-2.18],0.930915137065778
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23660,51,1.23 [0.65-2.32],0.5255309433698367
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23761,460,1.04 [0.82-1.32],0.7461691949805416
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23590,289,1.07 [0.79-1.44],0.6609210352357815
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23384,83,1.15 [0.67-1.96],0.6132060779292905
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23367,66,0.77 [0.37-1.61],0.4858616444125588
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23588,69,1.19 [0.67-2.12],0.5567014139396607
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23729,210,1.12 [0.79-1.58],0.5305691530338815
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23574,55,1.16 [0.59-2.28],0.6574510828697077
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza,22722,69,0.38 [0.16-0.89],0.0257917633064388
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22721,68,0.38 [0.16-0.89],0.0268488476563434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17629,117,1.20 [0.78-1.85],0.3978885059702461
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23716,272,1.07 [0.78-1.45],0.6824659788361651
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18910,1527,1.10 [0.97-1.25],0.1390267453273473
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19013,1501,1.10 [0.97-1.25],0.1296514128411153
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23596,84,1.07 [0.60-1.88],0.8238239577638974
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22703,50,1.24 [0.64-2.41],0.5251787187261974
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bronchiectasis,21201,155,1.22 [0.84-1.78],0.2981393757955882
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21080,34,0.51 [0.16-1.62],0.2531191678282667
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23077,2031,1.14 [1.02-1.28],0.0163829838320574
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22559,58,0.74 [0.49-1.12],0.1577186907214449
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22644,143,1.18 [0.80-1.76],0.4055813704941049
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23752,615,1.19 [0.97-1.44],0.0912129003047435
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22622,121,0.58 [0.32-1.05],0.0703242004952115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22158,3671,1.06 [0.98-1.16],0.162495121093504
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22839,338,0.73 [0.52-1.02],0.062529757667409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,23577,440,1.27 [1.02-1.59],0.0332541381572385
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Emphysema,21205,159,1.41 [0.93-2.15],0.1066254777471984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22728,100,0.99 [0.57-1.70],0.9651722210622876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23684,1031,0.97 [0.82-1.15],0.6990479261774991
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22748,120,1.15 [0.73-1.81],0.5412778476929527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Later onset COPD,22583,175,1.00 [0.65-1.53],0.998616171900696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23836,132,0.95 [0.59-1.53],0.8279252496113808
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,22603,102,1.01 [0.60-1.70],0.959765850223018
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23650,548,1.11 [0.89-1.37],0.357720652018065
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23688,1083,1.11 [0.95-1.29],0.171831360303898
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23276,775,0.95 [0.78-1.15],0.5772914287364165
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other pleural conditions,22638,33,1.29 [0.59-2.82],0.516513138757688
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23791,176,1.16 [0.80-1.67],0.4261562293074078
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23773,743,0.99 [0.81-1.20],0.9165760071337172
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,23122,517,1.43 [1.19-1.71],9.984418097185029e-05
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural plaque,22652,47,1.18 [0.59-2.36],0.6434331547964623
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23499,846,0.98 [0.82-1.18],0.8712948597126527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23819,115,0.98 [0.59-1.62],0.9329375018293672
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumothorax,22660,55,1.15 [0.58-2.25],0.6898361140059857
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,23812,232,1.03 [0.73-1.44],0.8745087634715045
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23651,36,1.78 [1.02-3.12],0.0440278754139312
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17544,32,0.97 [0.37-2.54],0.9463046133215728
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23630,528,1.09 [0.87-1.36],0.4544672648636092
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22773,272,1.06 [0.78-1.44],0.7248497363534743
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Viral pneumonia,22819,166,1.04 [0.69-1.57],0.8433307906516053
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23613,143,1.07 [0.70-1.66],0.7466134872710894
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13726,82,0.91 [0.49-1.71],0.7714500493165036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18233,56,1.00 [0.49-2.05],0.9945846759541038
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23668,133,1.40 [0.98-2.01],0.0658815248029268
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute gastritis,19051,60,0.85 [0.40-1.80],0.6684932983684806
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22449,148,1.02 [0.66-1.57],0.9437666458829592
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23460,58,1.52 [0.91-2.52],0.1064842507169254
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23169,73,1.35 [0.82-2.21],0.237799522709776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,19298,307,1.31 [1.02-1.69],0.0369853452436594
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22350,49,0.63 [0.25-1.57],0.3164437057362225
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23491,49,0.62 [0.25-1.55],0.3044504211911238
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,22457,156,1.02 [0.67-1.56],0.912321754135376
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,23110,809,1.06 [0.89-1.27],0.5202733277810577
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,19206,215,1.20 [0.87-1.65],0.2722540582761299
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22339,38,0.50 [0.17-1.51],0.2184021228161155
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23716,72,0.50 [0.22-1.11],0.0895593797223591
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,22599,97,1.02 [0.61-1.72],0.9400522569912804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Collagenous colitis,22487,48,0.93 [0.42-2.05],0.8608153311379203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23673,179,1.06 [0.72-1.56],0.7682281899999939
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Constipation,23658,1004,0.89 [0.75-1.07],0.2163652974282841
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn disease,22518,79,0.87 [0.46-1.64],0.661321121620955
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23540,53,0.96 [0.46-2.01],0.917516585795414
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22516,77,0.91 [0.49-1.71],0.7774587280028207
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Dental caries,23123,227,1.27 [0.94-1.71],0.1187942515202734
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22033,1550,1.09 [0.96-1.24],0.1833742201983499
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23706,171,1.37 [0.99-1.90],0.0541716886317706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,23739,643,1.21 [1.01-1.46],0.0421948789413205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22320,3329,1.01 [0.92-1.10],0.8761836487042399
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23425,529,1.20 [0.98-1.47],0.0831827850453569
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23773,371,1.14 [0.88-1.46],0.3254821254124196
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23009,113,1.13 [0.71-1.81],0.5996216475568481
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22874,60,0.93 [0.46-1.89],0.844730661941072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23599,1097,1.12 [0.96-1.30],0.1394987811400976
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22879,107,1.26 [0.81-1.95],0.3049304144750345
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23397,1096,1.05 [0.90-1.22],0.5441825072422561
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20293,2116,1.01 [0.90-1.13],0.8870403704654684
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19121,130,1.17 [0.76-1.81],0.4672570132894025
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23780,101,1.16 [0.71-1.88],0.5568700972561835
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23725,73,0.44 [0.20-0.98],0.0432227995617624
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23186,90,1.04 [0.60-1.80],0.8871479523194128
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18330,153,1.09 [0.72-1.64],0.6897668435179585
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19435,444,0.97 [0.75-1.25],0.8017601924542233
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,19240,249,0.98 [0.69-1.40],0.9248662186891262
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20927,1936,1.11 [0.99-1.24],0.0711644221047548
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19354,363,1.00 [0.75-1.33],0.9813217910087084
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19410,6918,1.03 [0.97-1.10],0.3550870221983011
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,23376,874,1.09 [0.92-1.30],0.3018612711898589
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22956,60,1.38 [0.80-2.39],0.2445252568165923
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18958,1101,0.98 [0.83-1.15],0.7784189996056503
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23142,46,1.35 [0.71-2.55],0.3545654785834243
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Hernia,22826,2343,1.08 [0.97-1.20],0.1537462861478475
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,23734,68,0.45 [0.20-1.02],0.0570543761661106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impaction of intestines,18207,30,1.33 [0.58-3.02],0.4992107036334142
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,21074,591,1.05 [0.84-1.30],0.6854696190180538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20552,69,1.32 [0.76-2.28],0.3200083031017451
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18240,63,1.61 [1.02-2.54],0.0417691895701495
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22618,116,1.00 [0.62-1.62],0.9916854552547012
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18680,503,0.89 [0.70-1.15],0.376313897502177
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23819,334,1.10 [0.84-1.45],0.4960591033521649
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23041,602,0.94 [0.75-1.18],0.5938954337436361
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23199,760,0.91 [0.74-1.11],0.332124062931466
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19117,126,1.14 [0.73-1.77],0.5588698794808533
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,19415,424,0.94 [0.72-1.23],0.657644615139257
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23806,116,0.74 [0.43-1.29],0.2913533261611506
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20526,43,1.28 [0.63-2.63],0.4976233112189721
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19309,1132,0.97 [0.83-1.14],0.7029992679386038
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22469,168,1.15 [0.79-1.67],0.4561674231213213
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22440,139,1.31 [0.91-1.88],0.1455766083192284
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,19499,1322,1.12 [0.98-1.28],0.0937278519649366
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22407,4230,1.00 [0.92-1.08],0.9356816087849826
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22881,167,0.80 [0.51-1.25],0.3297919413397437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23611,515,1.11 [0.89-1.39],0.3502976678549768
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19459,468,1.30 [1.06-1.60],0.0132102845151235
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22371,70,0.75 [0.37-1.55],0.4405221179699357
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23728,326,1.12 [0.85-1.47],0.4202964607501133
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19657,666,0.96 [0.78-1.19],0.7155742391248278
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23389,887,1.09 [0.92-1.29],0.3163576266728103
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23042,146,1.22 [0.83-1.78],0.3149805466350251
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19223,1046,0.93 [0.79-1.10],0.415983697756465
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20513,1522,0.97 [0.84-1.11],0.6350375416065878
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23167,71,1.33 [0.79-2.25],0.2809796238103476
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23100,661,0.94 [0.76-1.16],0.5707086668375875
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18380,203,1.23 [0.89-1.70],0.2143033519247262
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23711,86,0.52 [0.26-1.06],0.0735978008637933
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18480,303,1.21 [0.92-1.58],0.1689259312321573
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22627,125,1.37 [0.94-2.01],0.1026491580864498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23834,55,1.11 [0.57-2.16],0.7606272718744387
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22910,117,1.25 [0.82-1.90],0.2992296809768034
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Toxic colitis,22460,21,1.04 [0.33-3.23],0.9466684579618408
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19156,165,1.10 [0.74-1.63],0.6539337131240898
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22568,129,0.85 [0.51-1.41],0.5206527762483601
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22550,111,1.02 [0.62-1.67],0.9499417180005224
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20717,234,0.93 [0.64-1.34],0.6927812515137495
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18270,93,1.09 [0.64-1.83],0.7583169671710901
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,20682,199,1.28 [0.92-1.78],0.1494366489521039
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Volvulus,18235,58,1.02 [0.51-2.03],0.9663295365239222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23804,136,1.34 [0.94-1.92],0.1013971298375702
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23611,72,0.73 [0.36-1.50],0.3936458784138487
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22559,131,0.94 [0.59-1.51],0.8007812992466445
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23281,479,0.78 [0.59-1.03],0.0746047073416221
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22981,179,0.86 [0.56-1.33],0.495668583654766
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22574,146,1.05 [0.68-1.62],0.8411575685627447
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23618,202,0.82 [0.55-1.23],0.3432858617325098
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23757,341,0.93 [0.69-1.25],0.6089053789776666
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23452,36,0.97 [0.40-2.34],0.946627644283072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22564,2216,0.93 [0.83-1.04],0.2190772017092803
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23440,369,0.87 [0.65-1.17],0.3503658440170925
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23328,257,0.87 [0.61-1.23],0.4234632418279898
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23490,688,0.86 [0.69-1.07],0.1887058175154218
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23831,40,0.72 [0.28-1.85],0.4917618427726605
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22482,54,1.47 [0.86-2.51],0.1557073028284715
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23108,37,0.74 [0.27-2.00],0.5530841741329706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23612,196,0.83 [0.55-1.25],0.3765776855172066
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22683,255,1.02 [0.74-1.41],0.9019693421463064
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22462,34,0.53 [0.17-1.65],0.2738885791686676
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23773,62,0.47 [0.20-1.12],0.089576086726765
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22919,117,0.78 [0.45-1.36],0.3793055304440573
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23673,134,1.54 [1.09-2.16],0.0134961136838793
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23440,24,0.63 [0.17-2.31],0.4835672888674412
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22474,46,0.58 [0.22-1.51],0.2644331047365722
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23391,963,0.97 [0.82-1.15],0.7344737956033027
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22713,285,0.98 [0.72-1.34],0.893462560727581
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22465,37,0.87 [0.34-2.20],0.7656113024051526
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23772,233,1.15 [0.83-1.58],0.4074645986105739
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23471,55,1.19 [0.63-2.26],0.5947336680605757
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23730,191,1.26 [0.90-1.76],0.1783366514386621
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23817,149,1.33 [0.95-1.88],0.1011836885157197
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22538,110,0.85 [0.49-1.46],0.5488016877622257
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22596,168,0.85 [0.55-1.31],0.4581089534717809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23812,144,1.31 [0.92-1.86],0.1361992366529877
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22542,114,1.28 [0.82-2.01],0.2802482894914759
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23815,104,0.65 [0.35-1.20],0.1649034388869784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20890,117,1.00 [0.61-1.64],0.9863404503349082
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22234,4024,1.03 [0.95-1.12],0.4724980266724166
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21075,2865,1.07 [0.97-1.17],0.1738110221067662
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20858,85,1.01 [0.57-1.78],0.9849400869052236
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21363,135,1.32 [0.91-1.92],0.1419388480937068
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21370,142,0.58 [0.33-1.00],0.049695876843789
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23644,101,1.15 [0.71-1.84],0.5741702926806154
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21271,43,0.66 [0.25-1.72],0.3902995689716874
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18873,663,1.08 [0.89-1.31],0.4325457171747529
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23789,114,0.74 [0.42-1.30],0.2944946621768809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21480,252,0.85 [0.59-1.22],0.371927778348486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20819,5392,1.03 [0.96-1.10],0.4845552394402383
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22635,92,0.53 [0.27-1.08],0.0797094328496322
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20875,102,1.07 [0.63-1.82],0.8104637290259196
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21310,537,1.00 [0.79-1.25],0.9847481755686236
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23057,1829,1.01 [0.90-1.14],0.850200113302886
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20974,201,1.11 [0.78-1.59],0.5590148723102776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21033,260,1.17 [0.87-1.57],0.3042380848521809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20908,135,0.77 [0.46-1.28],0.3130746419057985
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23378,34,0.53 [0.17-1.65],0.271239467620559
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19341,1131,0.98 [0.83-1.14],0.7669890040915559
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18550,340,1.21 [0.93-1.56],0.1520929423411424
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23795,330,1.16 [0.88-1.52],0.2821240984179156
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18277,67,1.03 [0.54-1.94],0.9351597844418108
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18513,303,0.80 [0.57-1.11],0.1824063094002524
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21061,288,1.12 [0.84-1.50],0.4438957744106205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18869,659,1.01 [0.82-1.23],0.942323125041092
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21253,25,0.67 [0.19-2.36],0.5363776315609519
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21715,487,0.93 [0.73-1.19],0.5751225653458314
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21477,249,0.85 [0.59-1.22],0.3668962228846638
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18822,612,1.06 [0.86-1.30],0.595609997488776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20843,70,1.07 [0.57-2.00],0.8304998357857015
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20826,53,0.46 [0.18-1.17],0.1017873888319447
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22593,50,0.50 [0.19-1.31],0.1597428061757582
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23551,1008,1.04 [0.88-1.22],0.6428781534408686
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23117,574,1.13 [0.92-1.38],0.2466724928652159
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23737,301,1.23 [0.95-1.61],0.1230371728394692
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19764,1554,1.15 [1.02-1.30],0.0208737585751054
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18273,63,0.70 [0.44-1.09],0.1122204879062861
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20841,68,1.25 [0.72-2.17],0.4295594982211844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18235,25,1.69 [0.84-3.39],0.1425074807329566
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18307,97,1.13 [0.70-1.83],0.6225232725087861
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22745,202,0.92 [0.63-1.36],0.6858984088120643
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22754,211,1.23 [0.90-1.69],0.1912989724930862
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23807,74,1.47 [0.91-2.36],0.1142464996333123
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22590,1362,0.96 [0.83-1.11],0.586017195211552
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20880,107,1.00 [0.61-1.66],0.9857811295176896
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18319,109,1.14 [0.72-1.81],0.5673424939601233
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21783,555,1.03 [0.82-1.28],0.8121547182561556
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19989,1779,1.00 [0.89-1.14],0.9654795005400644
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23396,52,0.99 [0.47-2.07],0.9787645454626838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23819,69,0.62 [0.29-1.34],0.2273439907102281
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20843,70,1.72 [1.11-2.65],0.0152771910264328
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21737,964,1.20 [1.03-1.39],0.0215239319816834
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20832,59,1.11 [0.56-2.21],0.761438331254265
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19177,967,1.02 [0.86-1.20],0.8386839072872624
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22635,92,0.80 [0.43-1.47],0.4649499666386015
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20832,59,0.76 [0.35-1.65],0.4884603308876826
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21331,103,0.89 [0.52-1.54],0.6810792553497655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21117,344,1.28 [1.00-1.63],0.0543094064897084
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23534,190,1.37 [1.02-1.85],0.0355566957825156
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21639,411,0.97 [0.75-1.27],0.8484488786698379
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23746,286,1.26 [0.96-1.65],0.0894652253841198
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23827,33,1.68 [0.94-3.01],0.0798254134614362
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20954,181,1.34 [0.97-1.84],0.0747160697680491
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19108,532,0.93 [0.73-1.18],0.5369387273442696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21205,432,1.25 [1.00-1.56],0.0469514485233342
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20922,149,1.29 [0.89-1.87],0.1792466886658516
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18243,33,1.15 [0.51-2.62],0.7366618031008558
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19743,1533,1.09 [0.96-1.24],0.1745993800651804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18602,392,0.99 [0.75-1.29],0.9265587021239532
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23421,77,1.33 [0.82-2.15],0.2529620810731256
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23776,43,1.70 [0.99-2.93],0.0533398417979492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22448,24,0.83 [0.53-1.32],0.4356453315508167
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18281,71,0.64 [0.30-1.38],0.2562464373539119
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21306,78,0.83 [0.43-1.60],0.5711002940572882
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18514,304,1.25 [0.96-1.63],0.0911230305880829
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21010,237,1.21 [0.90-1.65],0.2105637948096561
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21414,186,1.01 [0.69-1.48],0.9656587380246732
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21321,93,0.93 [0.53-1.63],0.8071376299649281
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20152,41,1.30 [0.66-2.57],0.4440346414935832
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23830,36,1.68 [0.95-2.95],0.0723069164044547
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21297,524,1.08 [0.86-1.35],0.5206683992029357
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23422,78,1.41 [0.91-2.20],0.1257228062150423
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22900,2127,1.08 [0.97-1.21],0.1710393650166217
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20874,101,1.06 [0.63-1.78],0.8338290863539262
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21544,316,1.13 [0.86-1.49],0.3868794872304091
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22613,167,0.98 [0.65-1.48],0.9202659179308148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21359,131,0.80 [0.48-1.34],0.395966154619605
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22165,937,1.10 [0.94-1.29],0.2445304521549959
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21841,613,1.12 [0.92-1.37],0.2494604077640079
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20812,39,1.70 [0.98-2.94],0.056894513986024
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23478,134,0.98 [0.62-1.55],0.9229191393292856
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20907,134,0.86 [0.52-1.41],0.5501059173140848
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20826,53,0.77 [0.34-1.76],0.5416480127738017
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18243,33,1.48 [0.72-3.04],0.2873111209188528
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23392,726,1.07 [0.88-1.29],0.5144087190637844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9660,63,1.13 [0.62-2.06],0.7001337168918262
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12877,70,1.03 [0.56-1.89],0.9184036982267276
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23581,268,1.09 [0.80-1.48],0.5834445850307541
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23369,56,0.80 [0.36-1.77],0.5749757601901659
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23216,550,1.10 [0.89-1.37],0.3628719896259487
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23690,18,1.95 [0.98-3.88],0.0552884101716205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23698,157,0.77 [0.48-1.25],0.2889068626458121
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,21891,135,0.92 [0.57-1.48],0.7262880934587839
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,22707,41,1.09 [0.48-2.44],0.8399224305344883
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10304,982,0.96 [0.81-1.15],0.6613456729539999
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12980,173,1.00 [0.67-1.47],0.9828936880303863
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9712,115,1.06 [0.67-1.68],0.81629412641941
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9927,330,1.05 [0.80-1.38],0.7178517809424888
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9973,376,0.96 [0.73-1.26],0.7600288438542989
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20064,3663,0.99 [0.91-1.08],0.8829465540692998
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23726,54,1.09 [0.55-2.16],0.8018452170497579
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9394,72,0.80 [0.40-1.63],0.5433721684814634
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22592,191,1.04 [0.72-1.52],0.8188052948544768
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9975,653,1.06 [0.86-1.29],0.5853132698645496
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12864,206,1.07 [0.76-1.50],0.7013950940589406
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9413,91,1.28 [0.80-2.03],0.2979840537186706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,12874,106,0.73 [0.41-1.29],0.2812349664972346
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9856,259,1.11 [0.82-1.50],0.4929123346700395
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21813,57,0.75 [0.34-1.68],0.485377750778167
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10806,1209,1.08 [0.94-1.25],0.2954452076410119
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9369,47,1.59 [0.90-2.79],0.108545747481783
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9680,83,1.02 [0.58-1.80],0.9478795120295388
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23834,35,0.98 [0.39-2.44],0.9672011963257768
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23838,39,1.23 [0.58-2.59],0.5873704955134146
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23082,1326,1.05 [0.91-1.21],0.5179322718843797
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22176,420,1.01 [0.78-1.31],0.9384876217886948
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12860,53,0.40 [0.16-1.03],0.0584063835237721
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23800,259,0.96 [0.68-1.34],0.793513432787228
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9458,136,0.68 [0.39-1.17],0.1606109029563482
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9427,105,0.64 [0.34-1.20],0.1624960550193636
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9387,65,1.00 [0.52-1.93],0.9965571921345407
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23812,49,1.47 [0.85-2.54],0.172306075010429
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22727,971,0.97 [0.82-1.15],0.7203124004122115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12763,105,1.15 [0.73-1.80],0.553245381803575
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9668,71,1.46 [0.89-2.39],0.1369159046673005
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9795,198,1.39 [1.04-1.87],0.0274816988877376
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9648,51,0.87 [0.39-1.94],0.7319403851604941
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9686,89,1.01 [0.58-1.76],0.9656144675887498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22622,221,1.10 [0.78-1.54],0.5994142118704539
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23629,88,1.11 [0.65-1.90],0.6960809846696764
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9752,155,1.38 [1.00-1.92],0.0523348793907457
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9666,69,1.03 [0.55-1.93],0.9341702230177752
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9953,356,1.04 [0.79-1.36],0.7891670331687759
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9652,55,1.27 [0.68-2.37],0.4558776496026624
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9915,318,1.03 [0.77-1.38],0.8252234221661743
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23714,42,1.50 [0.82-2.73],0.185911442976624
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9418,96,0.90 [0.51-1.61],0.7286410740926913
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23687,1286,1.03 [0.89-1.19],0.7148199272237001
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22521,120,1.17 [0.75-1.81],0.4893490935461368
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22720,54,0.84 [0.38-1.85],0.6662747978446117
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23374,61,0.88 [0.42-1.84],0.731226994716708
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21905,149,1.36 [0.96-1.92],0.0835734631202575
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23639,326,1.04 [0.78-1.38],0.813404428710021
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9681,84,0.99 [0.56-1.76],0.9859117395403956
